Sa1570 NATIONWIDE TRENDS IN NAFLD HOSPITALIZATIONS (2016-2019) AMONG YOUNG NON-TOBACCO SMOKERS: THE ROLE OF CANNABIS USE DISORDER AND IMPACT OF SEX, RACE, AND CO-MORBIDITIES
Read More →
Maggio 2024
Risultati per: Linee guida tedesche sulla steatosi epatica non alcolica (NAFLD)
Questo è quello che abbiamo trovato per te
847 METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND NONALCOHOLIC FATTY LIVER DISEASE (NAFLD): CONCORDANCE OF CLINICAL PROFILES AND NON-INVASIVE TESTS PERFORMANCE
Read More →
Maggio 2024
Su1580 PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISAESE (MASLD)-RELATED CIRRHOSIS IN THE UNITED STATES
Read More →
Maggio 2024
Su1604 COMPARATIVE EFFECTIVENESS OF GLP-1RAS, SGLT-2 INHIBITORS, AND OTHER GLUCOSE-LOWERING DRUGS ON ADVERSE CARDIOVASCULAR AND MORTALITY OUTCOMES AMONG PATIENTS WITH DIABETES, NAFLD, AND CARDIOVASCULAR DISEASES: A LARGE POPULATIONBASED COHORT STUDY
Read More →
Maggio 2024
Su1599 PREVALENCE AND ASSOCIATION OF NAFLD IN METABOLICALLY HEALTHY OBESITY WITH COMORBIDITIES IN YOUNG ASIAN AMERICAN POPULATION: A NATIONWIDE INPATIENT PERSPECTIVE (2019)
Read More →
Maggio 2024
Su1619 PREVALENCE AND MORTALITY OF NAFLD, MAFLD, AND MASLD IN THE UNITED STATES FROM 1988-2019: A POPULATION-BASED ANALYSIS
Read More →
Maggio 2024
Su1544 RAD50 BLOCKS THE PROTECTIVE EFFECTS OF URIC ACID-LOWERING THERAPY AGAINST NAFLD IN FEMALES
Read More →
Maggio 2024
Su1568 A SYSTEMATIC REVIEW ON THE IMPACT OF GLP-1 AGONISTS ON NAFLD: A PROMISING NNT THAT CALLS FOR EARLY SCREENING AND TREATMENT
Read More →
Maggio 2024
Su1538 DIFFERENTIAL BRAIN ACTIVATION TO A FINE MOTOR TASK IN INDIVIDUALS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) COMPARED TO THOSE WITHOUT
Read More →
Maggio 2024
Su1573 UNHEALTHY FOOD CONSUMPTION IS A DRIVER OF MORTALITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN THE UNITED STATES (U.S.)
Read More →
Maggio 2024
Su1574 GUIDANCE TO IDENTIFY HIGH-RISK NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS COST EFFECTIVE
Read More →
Maggio 2024
Diagnosi e trattamento della vescica iperattiva idiopatica: linea guida
Read More →
Maggio 2024
Assistenza di sopravvivenza per persone affette da cancro avanzato o metastatico: linea guida
Read More →
Maggio 2024
Perdita dell’udito legata all’età: linea guida
Read More →
Maggio 2024
ACP: linee guida cliniche per i nuovi trattamenti del diabete tipo 2
Read More →
Aprile 2024
NICE: linee guida sulla diagnosi e gestione dell’endometriosi
Read More →
Aprile 2024
